» Articles » PMID: 1924323

B3(Fv)-PE38KDEL, a Single-chain Immunotoxin That Causes Complete Regression of a Human Carcinoma in Mice

Overview
Specialty Science
Date 1991 Oct 1
PMID 1924323
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

The genes encoding the heavy- and light-chain Fv regions of the monoclonal murine antibody B3, which recognizes a carbohydrate antigen on the surface of many human carcinomas, were cloned by PCR techniques and used to generate single-chain immunotoxins containing Pseudomonas exotoxin (PE). The light and heavy chains were connected by a flexible linker to form a single-chain antigen-binding protein, B3(Fv), which was in turn fused to truncated forms of PE lacking the cell-binding domain. The single-chain Fv and two different B3(Fv) immunotoxins, B3(Fv)-PE40 and B3(Fv)-PE38KDEL, were expressed in Escherichia coli and the single-chain immunotoxins were purified to near homogeneity. Both recombinant immunotoxins were shown to be cytotoxic specifically to carcinoma cell lines that express the B3 antigen on their surface; B3(Fv)-PE38KDEL was significantly more active. Furthermore, intravenous administration of B3(Fv)-PE38KDEL caused complete regression of human epidermoid carcinomas growing subcutaneously in immunodeficient mice.

Citing Articles

Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodies.

Dickopf S, Buldun C, Vasic V, Georges G, Hage C, Mayer K Biol Chem. 2022; 403(5-6):495-508.

PMID: 35073465 PMC: 9125802. DOI: 10.1515/hsz-2021-0401.


Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models.

Kuo W, Hsu H, Wu C, Chen H, Chou Y, Tsou Y MAbs. 2018; 11(1):153-165.

PMID: 30365359 PMC: 6343809. DOI: 10.1080/19420862.2018.1541370.


The Use of Plant-Derived Ribosome Inactivating Proteins in Immunotoxin Development: Past, Present and Future Generations.

Rust A, Partridge L, Davletov B, Hautbergue G Toxins (Basel). 2017; 9(11).

PMID: 29076988 PMC: 5705959. DOI: 10.3390/toxins9110344.


Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Demmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins.

Grinberg Y, Benhar I Biomedicines. 2017; 5(2).

PMID: 28574434 PMC: 5489814. DOI: 10.3390/biomedicines5020028.


An update in the use of antibodies to treat glioblastoma multiforme.

Hernandez-Pedro N, Rangel-Lopez E, Vargas Felix G, Pineda B, Sotelo J Autoimmune Dis. 2013; 2013:716813.

PMID: 24294521 PMC: 3835613. DOI: 10.1155/2013/716813.


References
1.
Hartman A, Rudikoff S . VH genes encoding the immune response to beta-(1,6)-galactan: somatic mutation in IgM molecules. EMBO J. 1984; 3(12):3023-30. PMC: 557806. DOI: 10.1002/j.1460-2075.1984.tb02249.x. View

2.
Kunkel T . Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985; 82(2):488-92. PMC: 397064. DOI: 10.1073/pnas.82.2.488. View

3.
Saiki R, Gelfand D, Stoffel S, Scharf S, Higuchi R, Horn G . Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988; 239(4839):487-91. DOI: 10.1126/science.2448875. View

4.
Kondo T, Fitzgerald D, Chaudhary V, Adhya S, Pastan I . Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain. J Biol Chem. 1988; 263(19):9470-5. View

5.
Huston J, Levinson D, Tai M, Novotny J, Margolies M, Ridge R . Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A. 1988; 85(16):5879-83. PMC: 281868. DOI: 10.1073/pnas.85.16.5879. View